Asclepix Therapeutics

Developing anti-angiogenic therapeutics

placeBaltimore, Maryland, United States calendar_todayFounded 2011 groups8 employees language asclepix.com

Registered entities

Investor mix

12 investors on record; lead investors include Perceptive Advisors, Xontogeny.

Investor typeCountShare
Venture capital650%
Private equity18%
Accelerator & incubator18%
Bank & private debt18%
Other / undisclosed325%
Coming soon